MALIGNANT RHABDOID TUMOR (MRT)

Clinical trials for MALIGNANT RHABDOID TUMOR (MRT) explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT RHABDOID TUMOR (MRT) trials appear

Sign up with your email to follow new studies for MALIGNANT RHABDOID TUMOR (MRT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with aggressive, rare cancers

Disease control Recruiting now

This study is testing whether three drugs given together can treat rare and aggressive childhood cancers caused by missing specific proteins. It will first find the safest dose and then see if the combination effectively controls these difficult tumors. The trial is for children …

Matched conditions: MALIGNANT RHABDOID TUMOR (MRT)

Phase: PHASE1, PHASE2 • Sponsor: Susan Chi, MD • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

MALIGNANT RHABDOID TUMOR (MRT)

Get alerted when new MALIGNANT RHABDOID TUMOR (MRT) trials appear

New hope for kids with aggressive, rare cancers